These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14175721)

  • 1. THE EFFECT OF HEPARIN ON FIBRINOLYTIC ACTIVATORS AND PLASMIN.
    NILSSON IM; BIELAWIEC M; BJOERKMAN SE
    Scand J Haematol; 1964; 1():75-88. PubMed ID: 14175721
    [No Abstract]   [Full Text] [Related]  

  • 2. THE EFFECT OF INDUCED FIBRINOLYSIS AND VARIOUS SUBSTANCES ON THE MAST CELLS IN THE PERITONEAL FLUID AND MESENTERY OF THE RAT.
    CRONBERG S; NILSSON IM
    Acta Pathol Microbiol Scand; 1964; 60():156-63. PubMed ID: 14121975
    [No Abstract]   [Full Text] [Related]  

  • 3. ENHANCING BLOOD FIBRINOLYTIC ACTIVITY BY A NIACIN COMPOUND. II. ACTIVATION AND NONACTIVATION.
    AMERY A; VERMYLEN J; DEVREKER RA; VERMYLEN C
    Am J Med Sci; 1965 Jan; 249():66-71. PubMed ID: 14254831
    [No Abstract]   [Full Text] [Related]  

  • 4. THE EFFECT OF SOME PHYSIOLOGICAL STIMULI ON FIBRINOLYTIC ACTIVITY IN MAN MEASURED BY THE HEPARIN FRACTIONATION METHOD.
    THOMSON WB; GREEN J; EVANS IL
    J Clin Pathol; 1964 May; 17(3):341-4. PubMed ID: 14159819
    [No Abstract]   [Full Text] [Related]  

  • 5. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY].
    DOUGLAS AS; MCNICOL GP
    Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145
    [No Abstract]   [Full Text] [Related]  

  • 6. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON INTRAVASCULAR CLOT LYSIS.
    LEWIS JH; KERBER CW; WILSON JH
    Am J Physiol; 1964 Nov; 207():1044-8. PubMed ID: 14237447
    [No Abstract]   [Full Text] [Related]  

  • 7. FIBRINOLYTIC AND ESTEROLYTIC ACTIVITY OF HUMAN PLASMA.
    ADAMIS DM; MANIATIS GM
    Thromb Diath Haemorrh; 1965 Jun; 13():484-91. PubMed ID: 14347870
    [No Abstract]   [Full Text] [Related]  

  • 8. [THERAPEUTIC FIBRINOLYSIS. I. STUDIES ON THE EFFECTS OF STREPTOKINASE AND ACTASE IN VITRO].
    JUERGENS J
    Klin Wochenschr; 1964 Jun; 42():534-8. PubMed ID: 14233281
    [No Abstract]   [Full Text] [Related]  

  • 9. A STANDARD CLOT METHOD FOR THE ASSAY OF PLASMINOGEN ACTIVATORS, ANTI-ACTIVATORS, AND PLASMIN.
    HAWKEY CM; STAFFORD JL
    J Clin Pathol; 1964 Mar; 17(2):175-81. PubMed ID: 14149945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CURRENT STATUS OF THROMBOLYTIC THERAPY.
    SHERRY S
    Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of epsilon-amino-caproic acid on prolactin-inactivating and fibrinolytic activities of streptokinase-activated plasminogen.
    HOPKINS TF; MEITES J
    Proc Soc Exp Biol Med; 1963 Apr; 112():830-2. PubMed ID: 13961684
    [No Abstract]   [Full Text] [Related]  

  • 12. THROMBOLYTIC THERAPY.
    FLUTE PT
    J Clin Pathol; 1964 May; 17(3):333-5. PubMed ID: 14159475
    [No Abstract]   [Full Text] [Related]  

  • 13. IMMUNOHISTOCHEMICAL STUDY OF THROMBOLYTIC MECHANISMS.
    BACK N; HIRAMOTO R; AMBRUS JL
    Blood; 1965 Jun; 25():1028-36. PubMed ID: 14294764
    [No Abstract]   [Full Text] [Related]  

  • 14. FIBRINOLYSIS AND THE PLASMA PROTEIN ELECTROPHORETIC PATTERN.
    BIELAWIEC M; NILSSON IM
    Scand J Clin Lab Invest; 1964; 16():513-20. PubMed ID: 14209211
    [No Abstract]   [Full Text] [Related]  

  • 15. [ON THE ACTION OF THROMBOLYTIC DRUGS].
    PATEL J; CORMIER JM
    Mem Acad Chir (Paris); 1964 Jun; 90():628-30. PubMed ID: 14179177
    [No Abstract]   [Full Text] [Related]  

  • 16. [THE FIBRINOLYTIC THERAPY OF EXPERIMENTAL MASSIVE PULMONARY EMBOLISM IN RABBITS].
    MATTIOLI G; RABITTI G; NAVA C
    Minerva Cardioangiol; 1964 Jan; 12():25-8. PubMed ID: 14130219
    [No Abstract]   [Full Text] [Related]  

  • 17. EFFECTS OF FEMALE HORMONES, USED AS ORAL CONTRACEPTIVES, ON THE FIBRINOLYTIC SYSTEM IN BLOOD.
    BRAKMAN P; ASTRUP T
    Lancet; 1964 Jul; 2(7349):10-2. PubMed ID: 14149193
    [No Abstract]   [Full Text] [Related]  

  • 18. ACTIVATION OF PARTIALLY PURIFIED PLASMINOGEN IN THE PRESENCE OF EPSILON-AMINOCAPROIC ACID. A TECHNIQUE FOR PREPARING PLASMIN FREE OF EXTRINSIC ACTIVATORS.
    DONALDSON VH
    J Lab Clin Med; 1964 Feb; 63():213-23. PubMed ID: 14125108
    [No Abstract]   [Full Text] [Related]  

  • 19. THE ROLE OF FIBRINOLYSIS IN THE TREATMENT OF ARTERIAL THROMBOSIS: EXPERIMENTAL AND CLINICAL ASPECTS.
    TSAPOGAS MJ
    Ann R Coll Surg Engl; 1964 May; 34(5):293-313. PubMed ID: 14145330
    [No Abstract]   [Full Text] [Related]  

  • 20. THROMBOLYTIC THERAPY.
    DOUGLAS AS; MCNICOL GP
    Proc R Soc Med; 1964 Jul; 57(7):609-14. PubMed ID: 14178954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.